Niki BioSolutions NIKI
NASDAQ NIKI
$1.81 -0.13 (-6.70%)
As of: Oct 23, 2026 · 12:53 PM EDT

Niki BioSolutions (NIKI) Operating Income (2024 - 2025)

Updated

Niki BioSolutions' Operating Income was -$935,982 in FY2025.

Analysis

Niki BioSolutions (NIKI) Operating Income (2024 - 2025) Analysis & Trends

From FY2022 onward, Niki BioSolutions has reported Operating Income for 4 years.

  • Per Business Quant data, Operating Income in earlier years was -$451,403 in FY2024, $11.17 million in FY2023 (-40.9%) and $18.89 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Eli Lilly 1,131.67 Bn 1,100.25 Bn 19.71 Bn 11.75 Bn
2 Johnson & Johnson 635.68 Bn 555.54 Bn 17.30 Bn 6.18 Bn
3 AbbVie 504.96 Bn 478.07 Bn 12.70 Bn 6.43 Bn
4 Merck 357.95 Bn 312.33 Bn 12.21 Bn -584.00 Mn
5 Novartis Ag 290.91 Bn 254.90 Bn 11.24 Bn 4.75 Bn
6 Astrazeneca 265.07 Bn 238.76 Bn 12.86 Bn 3.16 Bn
7 Amgen 237.58 Bn 192.98 Bn 7.24 Bn 3.51 Bn
8 Gilead Sciences 194.90 Bn 169.10 Bn 6.22 Bn -10.39 Bn
9 Pfizer 171.11 Bn 117.76 Bn 10.94 Bn 4.27 Bn
10 Niki BioSolutions 987,011.07 746,696.07 - -
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2025 -574,699.00
Nov 30, 2024 -82,713.00
Aug 31, 2024 -150,079.00
API Access

Niki BioSolutions Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-income&ticker=NIKI&period=max&api_key=YOUR_API_KEY